DK1237856T3 - Nye tri-substituerede phenylderivater og analoger - Google Patents

Nye tri-substituerede phenylderivater og analoger

Info

Publication number
DK1237856T3
DK1237856T3 DK00983619T DK00983619T DK1237856T3 DK 1237856 T3 DK1237856 T3 DK 1237856T3 DK 00983619 T DK00983619 T DK 00983619T DK 00983619 T DK00983619 T DK 00983619T DK 1237856 T3 DK1237856 T3 DK 1237856T3
Authority
DK
Denmark
Prior art keywords
analogs
substituted phenyl
phenyl derivatives
novel tri
tri
Prior art date
Application number
DK00983619T
Other languages
Danish (da)
English (en)
Inventor
Maria Boije
Jonas Faegerhag
Alstermark Eva-Lotte Lindstedt
Bengt Ohlsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1237856T3 publication Critical patent/DK1237856T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00983619T 1999-12-03 2000-11-29 Nye tri-substituerede phenylderivater og analoger DK1237856T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904421A SE9904421D0 (sv) 1999-12-03 1999-12-03 New compounds
PCT/SE2000/002385 WO2001040172A1 (en) 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues

Publications (1)

Publication Number Publication Date
DK1237856T3 true DK1237856T3 (da) 2004-08-02

Family

ID=20417986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983619T DK1237856T3 (da) 1999-12-03 2000-11-29 Nye tri-substituerede phenylderivater og analoger

Country Status (23)

Country Link
US (1) US6750252B2 (enExample)
EP (1) EP1237856B1 (enExample)
JP (1) JP2003515583A (enExample)
KR (1) KR100787072B1 (enExample)
CN (1) CN1206212C (enExample)
AR (1) AR033957A1 (enExample)
AT (1) ATE266633T1 (enExample)
AU (1) AU766533B2 (enExample)
BR (1) BR0016130A (enExample)
CA (1) CA2392039A1 (enExample)
DE (1) DE60010747T2 (enExample)
DK (1) DK1237856T3 (enExample)
ES (1) ES2219425T3 (enExample)
IL (2) IL149517A0 (enExample)
MX (1) MXPA02005223A (enExample)
MY (1) MY124727A (enExample)
NO (1) NO20022590L (enExample)
PT (1) PT1237856E (enExample)
SE (1) SE9904421D0 (enExample)
TR (1) TR200401716T4 (enExample)
TW (1) TWI224590B (enExample)
WO (1) WO2001040172A1 (enExample)
ZA (1) ZA200203798B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU1198699A (en) 1997-10-27 1999-04-23 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
AU749505B2 (en) 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
CA2307068C (en) 1997-10-27 2007-04-10 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
JP2002528535A (ja) 1998-10-29 2002-09-03 ドクター・レディーズ・リサーチ・ファウンデーション 新規抗糖尿病剤製造の改良方法
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
SE0101386D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
CN1589258A (zh) * 2001-10-16 2005-03-02 雷迪实验室有限公司 新的β－苯基－α－氧取代的丙酸衍生物,它的制备方法和它们制备药学上重要的化合物的应用
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
TW200817369A (en) * 2006-05-22 2008-04-16 Elan Pharm Inc Preparation of polymer conjugates of therapeutic, agricultural and food additive compounds
JP5404429B2 (ja) 2007-03-08 2014-01-29 アルビレオ・アクチボラグ ２−置換３−フェニルプロピオン酸誘導体および炎症性腸疾患の治療におけるそれらの使用
FR2917086B1 (fr) * 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2917084B1 (fr) 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
IL149517A (en) 2007-07-04
WO2001040172A1 (en) 2001-06-07
AU766533B2 (en) 2003-10-16
DE60010747D1 (de) 2004-06-17
KR100787072B1 (ko) 2007-12-21
MY124727A (en) 2006-06-30
AU2035101A (en) 2001-06-12
TWI224590B (en) 2004-12-01
US6750252B2 (en) 2004-06-15
CA2392039A1 (en) 2001-06-07
EP1237856B1 (en) 2004-05-12
DE60010747T2 (de) 2005-05-19
SE9904421D0 (sv) 1999-12-03
ATE266633T1 (de) 2004-05-15
CN1402703A (zh) 2003-03-12
IL149517A0 (en) 2002-11-10
NO20022590L (no) 2002-07-29
NO20022590D0 (no) 2002-05-31
EP1237856A1 (en) 2002-09-11
ZA200203798B (en) 2003-10-29
BR0016130A (pt) 2002-08-20
US20030149104A1 (en) 2003-08-07
JP2003515583A (ja) 2003-05-07
ES2219425T3 (es) 2004-12-01
CN1206212C (zh) 2005-06-15
PT1237856E (pt) 2004-08-31
TR200401716T4 (tr) 2004-09-21
MXPA02005223A (es) 2003-09-25
AR033957A1 (es) 2004-01-21
KR20020067537A (ko) 2002-08-22

Similar Documents

Publication Publication Date Title
DK1237856T3 (da) Nye tri-substituerede phenylderivater og analoger
NO20033715D0 (no) Nye sammensetninger
FI965126A7 (fi) Tri-substituoidut PDE IV -inhibiittoreina hyödylliset fenyylijohdannaiset
DE50210090D1 (de) Substituierte phenylderivate
DK1261585T3 (da) Substituerede indol-Mannichbaser
EE200200224A (et) Uudsed ühendid
NO20015074L (no) Nye sammensetninger
NO20020810D0 (no) Nye fenylpiperaziner
ATA55499A (de) Zusammenlegbarer tretroller
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
ATE339438T1 (de) Substanziell kristalline form von melagatran
EE200100537A (et) Maduuraftalasiini derivaatide kasutamine proinflammatoorsete tsütokiinide inhibiitoritena
NO20022971D0 (no) Butyndiol-derivater
DE60008319D1 (de) IL-12 Produktionsinhibitor
SE9904334D0 (sv) Novel bacterial isolate
DK1112262T3 (da) Substituerede gamma-delta-lactamer og analoger deraf og anvendelser relateret dertil
DK199900332U3 (da) Konservering af naturprodukter
ATA6699A (de) Tor
IT1318170B1 (it) Dispositivo per il raffreddamento di un massello o segmento di barrametallico
SE9901118D0 (sv) Novel compounds
SE9901078D0 (sv) Novel compounds
SE9904651D0 (sv) Novel compounds
SE9903838D0 (sv) Novel compounds
SE9903080D0 (sv) Novel compounds